PRESS RELEASE published on 07/31/2025 at 00:00, 4 months 5 days ago Inka Health Selected by OneMedNet to Lead AI-Driven Oncology Project Using Real-World Data for External Control Arms Onco-Innovations Limited's subsidiary, Inka Health Corp., selected by OneMedNet Corporation for data analytics initiative to improve cancer therapy processes and accelerate market entry for new therapies Real-world Evidence Cancer Therapies Onco-Innovations Limited Inka Health Corp. OneMedNet Corporation
BRIEF published on 07/30/2025 at 03:35, 4 months 6 days ago Onco-Innovations Limited annonce un placement privé sans intermédiaire Recherche Et Développement Placement Privé Approbations Réglementaires Actions Et Bons De Souscription Onco-Innovations
BRIEF published on 07/30/2025 at 03:35, 4 months 6 days ago Onco-Innovations Limited Announces Non-Brokered Private Placement Private Placement Research And Development Regulatory Approvals Shares And Warrants Onco-Innovations
PRESS RELEASE published on 07/30/2025 at 03:30, 4 months 6 days ago Onco-Innovations Announces Private Placement Onco-Innovations Limited announces a non-brokered private placement of up to 243,903 units at $1.64 per unit for proceeds of $400,000. Additionally, incentive stock options and restricted share units are granted. Company focuses on cancer research and treatment Private Placement Incentive Stock Options Cancer Research Restricted Share Units Onco-Innovations Limited
BRIEF published on 07/21/2025 at 06:05, 4 months 15 days ago Onco-Innovations Welcomes Dr. Dennis Hall to Advisory Board Cancer Research Onco-Innovations PNKP Inhibitor Dennis Hall Precision Therapies
BRIEF published on 07/21/2025 at 06:05, 4 months 15 days ago Onco-Innovations accueille le Dr Dennis Hall au sein de son conseil consultatif Recherche Sur Le Cancer Onco-Innovations Inhibiteur De PNKP Dennis Hall Thérapies De Précision
PRESS RELEASE published on 07/21/2025 at 06:00, 4 months 15 days ago Onco-Innovations Appoints Dr. Dennis Hall to Scientific & Clinical Advisory Board Onco-Innovations Limited appoints Dr. Dennis Hall, renowned chemist, to Scientific and Clinical Advisory Board. Dr. Hall brings expertise in boron chemistry, catalysis, and drug discovery to advance innovative oncology-focused therapies Scientific Advisory Board Oncology Onco-Innovations Limited Dr. Dennis Hall Boron Chemistry
BRIEF published on 07/12/2025 at 00:05, 4 months 24 days ago Onco-Innovations s'associe à Redwood AI pour le développement d'inhibiteurs de PNKP Traitement Du Cancer Développement De Médicaments Onco-Innovations Inhibiteur De PNKP IA Redwood
BRIEF published on 07/12/2025 at 00:05, 4 months 24 days ago Onco-Innovations Partners with Redwood AI for PNKP Inhibitor Development Cancer Treatment Drug Development Onco-Innovations PNKP Inhibitor Redwood AI
PRESS RELEASE published on 07/12/2025 at 00:00, 4 months 24 days ago Onco-Innovations Signs Agreement with Redwood AI to Advance Discovery and Evaluation of Its PNKP Inhibitor Technology Onco-Innovations partners with Redwood AI for drug development, leveraging AI-driven chemistry tools to enhance cancer therapy with PNKP Compound. Vancouver-based collaboration aims to improve research efficiency Cancer Therapy Onco-Innovations PNKP Compound Redwood AI AI-driven Chemistry
Published on 12/05/2025 at 19:20, 3 minutes ago The Multi-Sector Validation Shock: Why SMX Became Impossible for Markets to Ignore
Published on 12/05/2025 at 18:45, 38 minutes ago Four Global Markets, One Engine: SMX Just Redefined What a Supply Chain Can Prove
Published on 12/05/2025 at 18:20, 1 hour 3 minutes ago NuRAN Announces Intention to Complete Consolidation in Preparation to the Restructuring Transaction
Published on 12/05/2025 at 18:00, 1 hour 23 minutes ago SMX: A New Supply Chain Reality in the World's Four Largest Markets
Published on 12/05/2025 at 17:15, 2 hours 8 minutes ago TRX GOLD Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 18:58, 25 minutes ago EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:15, 1 hour 8 minutes ago Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:46, 1 hour 37 minutes ago Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds
Published on 12/05/2025 at 17:18, 2 hours 5 minutes ago La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 2 hours 5 minutes ago The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 4 hours 13 minutes ago Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 4 hours 13 minutes ago Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 5 hours 25 minutes ago RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE